caspase inhibitors has to date been restricted to cova-
Figure 1. Overall Structure of the Complex between Caspase-7 and an XIAP Fragment
The complex is viewed from three perpendicular angles to exhibit general features of this association (panels A, B, and C). The two heterodimers of caspase-7 are shown in green and orange, respectively. The bound XIAP fragments are highlighted in pink and blue, respectively. The catalytic residue Cys186 is colored in yellow. Some of the secondary structural elements are labeled. In panel (D), the experimental electron density map, shown at 2.5 , was calculated using phases generated from the molecular replacement solution of caspase-7 after only positional refinement. The final refined model of the XIAP fragment is also included as a yellow coil. Figures 1, 2, and 3 were prepared using MOLSCRIPT (Klaulis, 1991). lently bound tetrapeptides. In particular, there is no pase-7 is opposite to that of the tetrapeptide inhibitor.
In addition, we demonstrate that the BIR domains are structural information on any caspase bound to a natural inhibitor. dispensable for caspase-7 inhibition as their primary role is to maintain a productive conformation for the To reveal the mechanisms of effector caspase inhibition by IAPs and to provide a basis for improved drug linker peptide. Furthermore, we suggest a mechanism for the removal of IAP inhibition to effector caspases by design, we have determined the crystal structure of an active caspase-7 bound to a potent inhibitory domain Smac/DIABLO. These results provide not only a structural mechanism for effector caspase inhibition but also from XIAP (residues 124-240). The amino-terminal fragment of this XIAP domain fits tightly in the catalytic a useful framework for drug design. groove on the surface of caspase-7, making numerous hydrogen bonds and van der Waals contacts to surResults rounding residues. Comparing the binding mode to that of the tetrapeptide-bound caspases reveals a con-
Rationale and Structure Determination
The intervening linker region between the BIR1 and BIR2 served pattern of interactions. However, the relative orientation of the XIAP fragment with respective to casdomains of XIAP was recently shown to be critically important for the inhibition of caspase-3 (Sun et al., Each heterodimer of caspase-7 contains a central 6-stranded ␤ sheet ( Figure 1A ). The ␤ sheet is sur-1999). Interestingly, although mutation of several critical residues in the linker region abolished caspase-3 inhibirounded by two ␣ helices (␣2 and ␣3) and three short ␤ strands on one side and by three ␣ helices (␣1, ␣4, tion, the linker peptide by itself showed no inhibition, suggesting additional role by the BIR domains (Sun et and ␣5) and a ␤ hairpin on the other side. The two heterodimers of caspase-7 interact through a large hyal., 1999). Indeed, a fragment of XIAP (residues 124-240), comprising the complete linker peptide and the BIR2 drophobic surface, adopting a compact globular shape. The two central ␤ sheets from both subunits associate domain, was found to potently inhibit caspase-3 . This domain interacts strongly with both to form a single twisted 12-stranded ␤ sheet, resulting in an apparent single folding unit ( Figure 1C ). active caspase-3 and active caspase-7 and inhibits their catalytic activities (data not shown). We purified this Four prominent surface loops in each heterodimer connect the secondary structural elements and protrude XIAP fragment and the active caspase-7 or caspase-3 to homogeneity separately and reconstituted binary from the structural core, forming the substrate binding cleft (Figure 1 ). The catalytic residue Cys186, located complexes.
Although crystals of complexes involving both cason loop L2, is at the bottom of this cleft (Figure 1 ). Other residues important for the enzymatic activity of pases were obtained, only those with caspase-7 exhibited reasonable diffraction quality. Crystals were grown caspase-7 line the inner surface of this cleft. The bound XIAP fragment starts with a short ␣ helix at room temperature and are in the spacegroup P3 2 21. The caspase-7 structure was located by molecular refollowed by an extended segment (Figure 1 ). The XIAP linker peptide interacts with the catalytic groove and placement using atomic coordinates of caspase-3 as the initial search model (PDB code 1CP3). The electron fills the substrate binding pocket. There are 10 intermolecular hydrogen bonds and numerous van der Waals density for the bound XIAP fragment became immediately apparent after preliminary refinement ( Figure 1D) . contacts between the XIAP fragment and surrounding loops in caspase-7, involving both main chain and side The final atomic model has been refined to a crystallographic R factor of 23.6% (R free 27.2%) at 2.45 Å resoluchain atoms. The tertiary and quaternary structure of caspase-7 tion, with excellent stereochemical parameters ( (Figure 2) . The caspase-7-bound large solvent cavity immediately next to the carboxyl XIAP fragment overlaps with the covalently bound tetraterminus of this XIAP fragment, which is much larger peptide inhibitor to caspase-3 (Figure 2 ). than what is needed to accommodate the disordered BIR2 domain. As will be discussed in detail, this small fragment fully accounts for XIAP inhibition to effector
Interface between XIAP and Caspase-7 The substrate binding pocket on caspase-7 is formed caspases. The final refined model of the complex contains a complete catalytic unit of caspase-7 comprising by four surface loops, L1, L2, L3, and L4 (Figures 3 and  4) . The catalytic dyad residues, Cys186 and His144, are two p20-p10 heterodimers and two tightly-bound XIAP fragments (Figure 1) .
positioned at the bottom of this pocket. Binding of the of Gly144 in XIAP is in close contact with the catalytic dyad residues Cys186 and His144. The other binding region involves predominantly hydrogen bonds, with residues from the C-terminal half of the extended XIAP segment networking with caspase-7 residues on loops L3 and L4 ( Figure 3D and 4) . At the center of this network, the carboxylate side chain of Asp148 on XIAP accepts two intermolecular hydrogen bonds, one from the N⑀1 atom of Trp240 and the other from the backbone amide nitrogen of Gln276 ( Figure  3D ). In addition, the amide groups of Asp148 and Ile149 each donates one hydrogen bond to the carbonyl oxygen of Arg233 and Gln276, respectively ( Figure 3D ). The anchoring interactions involving Asp148 are buttressed by additional hydrogen bonds between Ser150 of XIAP and Arg237 and Gln276 of caspase-7 ( Figure 3D ).
Mechanisms of Caspase-7 Inhibition by XIAP
Previous work has identified several residues in XIAP that are important for the inhibition of caspase-3 activity. In particular, mutation of Asp148 or Leu141 to Ala nearly abolished the inhibition, while mutations of several other residues, including Val147 and Ile149, decreased inhibition significantly . Our crystal structure reveals that Leu141 and Asp148 play a central role in the recognition of caspase-7, serving as the anchoring residues for the hydrophobic and hydrophilic contact regions, respectively. On the other hand, Val147 and Thus we predict that mutation of this residue will inactivate XIAP inhibition of caspase-7.
Previous studies have identified the catalytic residues XIAP fragment completely fills this pocket, thus blocking in caspase-7 as well as residues important for substrate substrate entry ( Figure 3A The catalytic dyad residues are shown in red whereas the conserved amino acids are highlighted in yellow. Red and yellow arrows identify those residues that make intermolecular hydrogen bonds using their side chain and main chain atoms, respectively. The residues that contribute to intermolecular van der Waals contacts are marked with brown squares. The residues whose mutation abolished or decreased caspase-3 inhibition are shown as red and green circles, respectively. The secondary structural elements as well as the four loops in XIAP-BIR3 are indicated above the sequence alignment.
van der Waals contacts and hydrogen bonds to the cient for binding and inhibiting caspase-3 or -7. The BIR2 domain is completely disordered in the crystals, surrounding caspase-7 residues, respectively. Both Asp148 of XIAP and the P4 residue in the tetrapeptide suggesting that the interaction, if any, between BIR2 and caspase-7 must be weak. Indeed, we can not detect inhibitor make hydrogen bonds to Gln276 in caspase-7 ( Figure 5 ). stable complex formation using a variety of biochemical techniques including gel filtration, GST-mediated pullThus, four residues on XIAP, Gly144-Val146-Val147-Asp148, interact with the S1-S2-S3-S4 sites on caspase-7 down assays, and native gel electrophoresis (data not shown). This apparent discrepancy led us to hypotheby occupying the P1-P2-P3-P4 positions, respectively. The P1 position is occupied by the amino-terminal size that the linker peptide by itself adopts an "unproductive" conformation incapable of forming an inhibitory Gly144 of these four residues. This orientation is the reverse of that observed for the tetrapeptide caspase complex with caspase-3 or -7. In this case, the BIR domain might simply be required to avoid the unproducinhibitor, in which the P1 position is occupied by the carboxy-terminal Asp (Wei et al., 2000) . Strikingly, detive conformation for the peptide, and not for direct binding and inhibition of caspase-3 or -7. Because the spite this reversal in orientation, a significant subset of the interactions is conserved between these complexes BIR domain can be attached either N-or C-terminal to the linker peptide, we reasoned that this unproductive ( Figure 5) . conformation could be avoided by tethering at least one terminus of the linker peptide to a folded domain. This Dispensable Role of BIR2 in Caspase-7 Binding and Inhibition hypothesis, if verified true, would explain both the experimental data and the role of the BIR domains. Although residues in the linker region between the BIR1 and BIR2 domains of XIAP play a central role in the If our hypothesis is correct, then other proteins, when fused to either terminus of the linker peptide, should inhibition of caspase-3, the linker region by itself was found to be insufficient for inhibiting caspase-3, sugalso be able to prevent the unproductive conformation, allowing the linker peptide to bind and to inhibit casgesting that the linker peptide alone is unable to bind caspase-3 (Sun et al., 1999) . This result led to the conclupase-3 and -7. To test this conjecture, we created a fusion protein between glutathione-S transferase (GST) sion that the BIR domain may be indispensable for caspase inhibition (Sun et al., 1999) . However, given the and the linker peptide (residues 124-157) and examined possible interactions with active caspase-3 or -7 using fact that neither BIR1 nor BIR2 domain by itself binds or inhibits caspase-3 (Sun et al., 1999), this observation glutathione resin-mediated pulldown assays. The results demonstrate that, indeed, both caspase-3 and casappears quite perplexing. More surprisingly, an engineered protein with the linker peptide fused either Npase-7 interact strongly with the GST-linker peptide fusion ( Figure 6A, lane 2) . As a negative control, a fusion or C-terminal to the BIR1 domain was fully able to bind and inhibit caspase-3 (Sun et al., 1999) .
protein between GST and BIR2 (residues 156-240) was unable to interact with either caspase-3 or caspase-7 Our crystal structure, on the other hand, clearly demonstrates that the linker peptide by itself should be suffi- (Figure 6, lane 3) . To assess the strength of interactions, subjected to gel filtration analysis ( Figure 7B, Figure  7C ). Although this model is consistent with our biochemical and structural evidence, more detailed studies are needed. BIR3 does not show any inhibitory effect toward caspase-3 and -7. A recent report identified the linker region between the BIR1 and BIR2 domains of XIAP to be we quantified the binding affinity using isothermal titration calorimetry ( Figure 6B ). The best fit of the binding critically important for caspase-3 inhibition. However, the removal of the BIR domain led to complete loss of data gives rise to a dissociation constant of 0.63 Ϯ 0.04 M for a complex between caspase-7 and GST-linker inhibition by the linker peptide, prompting a conclusion that the BIR domains may be important for the inhibition peptide ( Figure 6B ). In contrast, neither GST nor the linker peptide alone binds caspase-7 detectably (data of caspsae-3 or -7 (Sun et al., 1999). In this study, we demonstrate that the BIR domains are dispensable for not shown).
Discussion

It was recently realized that different BIR domains in the
Next, we examined whether the GST-linker peptide the inhibition of caspase-3 and -7. A fusion protein between GST and the linker peptide of XIAP tightly binds could inhibit the enzymatic activity of caspase-7. Using the fluorogenic peptide Asp-Glu-Val-Asp-AFC as the to and potently inhibits caspase-7 and -3. These results strongly indicate that one of the primary roles of the substrate, GST-linker peptide potently inhibits caspase-7 activity, with an IC 50 value of ‫001ف‬ nM ( Figure 6C ). This flanking BIR domains is to relieve the linker peptide from an unproductive conformation that precludes binding result is in good agreement with the IC 50 value of 67 nM for the XIAP-BIR1-linker peptide fragment. In sharp to and inhibition of caspase-3 and -7. Although the BIR2 domain is disordered in the crystals, it is important to contrast, neither GST nor the peptide by itself (residues 124-157) exhibited any detectable inhibition toward casrealize that this domain is not unstructured or unfolded. We simply do not "see" this domain because it wobbles pase-7 at 1 M concentration (data not shown).
in the solvent cavity in the crystals. These results are in excellent agreement with reported Relief of XIAP Inhibition to Caspase-7 by Smac The inhibition of caspase-7 by XIAP can be removed by experimental observations. In particular, our study explains (1) why the BIR domain can be attached to either Smac ( Figure 7A) . One way to achieve this is through mutual exclusion of caspase-7 and Smac for binding to the N or the C terminus of the linker peptide with similar inhibitory effect , and (2) why the BIR XIAP. To examine this scenario, a complex between active caspsae-7 and XIAP (residues 124-240) was incudomain can be either BIR1 or BIR2 (Sun et al., 1999) . In fact, the BIR domain can be replaced by GST; the rebated with the mature form of Smac protein and then sulting fragment still retains similar levels of inhibition the BIR domains by GST resulted in similar levels of inhibition. Nevertheless, we can not rule out a minor role to the enzymatic activities of caspase-3 and -7. Although restraining one terminus of the linker peptide allows for the BIR domains in caspase inhibition. Although the BIR2 domain is dispensable for caspase-7 inhibition, it inhibition of caspase-7, it is possible that tethering both termini exhibits a stronger effect. Indeed, GST-linkermay have other important biological functions besides restraining the conformation of the linker peptide. For BIR2 (residues 124-240) appears to exhibit more potent inhibition to caspase-7 than either GST-linker or linkerexample, the BIR2 domain may be necessary for the relief of XIAP inhibition to caspase-7 or caspase-3 be-BIR2 alone (data not shown).
Interestingly, a number of residues on the XIAP-BIR2 cause Smac binds this domain but does not interact directly with the XIAP linker peptide. domain exhibited chemical shift changes upon binding to caspase-3, suggesting involvement in interactions What unproductive conformations could the linker peptide adopt? There are at least two possibilities. One (Sun et al., 1999) . However, a closer examination of these residues suggests that the interactions involved may not involves tight intramolecular interactions, perhaps requiring both termini to be free. The linker peptide with be biologically significant. First, most of these residues, such as Tyr154, Asn157, Tyr161, Gln197, Gln199, and this conformation, dubbed "knot," may exist as a monomer. The other possibility is that the linker peptides Lys208, are not conserved among any two BIR domains in XIAP or cIAP-1. This aspect is not in agreement with aggregate to form higher-order complexes. In both scenarios, the tethering of BIR domains or GST prevent the fact that both cIAP-1 and XIAP can potently inhibit caspase-3. Second, mutation of these residues does the unproductive conformations. More detailed study is needed to differentiate between these two possibilities. not affect the inhibition of XIAP to caspase-3 (Sun et  al., 1999) . Third, and most importantly, replacement of Our structural analysis shows that the XIAP linker pep- tide wraps around the active site of caspase-7, thus tacts to XIAP, only 7 are conserved in caspase-9 ( Figure  4 ). In addition, the critical L4 loop is significantly shortprecluding substrate entry and binding. Interestingly, the orientation of the XIAP peptide with respect to caspaseened in caspase-9 (Figure 4) , likely affecting the overall shape of the catalytic cleft. 7 is reversed relative to the orientation of the inhibitory tetrapeptide aldehyde Asp-Glu-Val-Asp-CHO. NonetheTwo other IAPs, cIAP-1 and cIAP-2, are also known to inhibit caspase-3 and -7. Sequence alignment among less, many of the detailed atomic interactions are conserved. It is striking that nature has chosen an opposite IAPs suggests that the mode of binding or inhibition should be conserved. For example, the two anchoring orientation of caspase inhibitor. Thus, this finding opens new avenues for the design of caspase inhibitors. residues in XIAP, Leu141 and Asp148, are invariant in both cIAP-1 and cIAP-2. However, comparing to XIAP, Caspase-3 shares 54% sequence identity with caspase-7. Consequently, the backbone structures of casthe inhibitory constants for cIAP-1 and c-IAP2 are about 100-fold weaker (Deveraux and Reed, 1999) . Our strucpase-3 and -7 are nearly identical (Figure 2) . In particular, 70% of the caspase-7 residues that interact with XIAP tural analysis provides a reasonable explanation. In XIAP, four residues, Gly144-Val146-Val147-Asp148, play are preserved in caspase-3 (Figure 4) . Thus, it is very likely that XIAP binds caspase-3 in the same manner as a central role by occupying the S1-S2-S3-S4 sites on caspase-7. Gly144 makes van der Waals contacts to it binds caspase-7. In support of this prediction, the GST-linker peptide interacts strongly with caspase-3 the catalytic dyad residues Cys186 and His144. In cIAP-1 and cIAP-2, however, at least two of these four (Figure 6 ).
Sequence alignment among caspase-3, -7, and -9 critical residues have been replaced. These four residues are Arg164-Val166-Glu167-Asp168 and Arg149-also reveals the structural basis for the observation that the XIAP linker peptide does not interact with caspase-9.
Asn151-Gln152-Asp153 for cIAP-1 and cIAP-2, respectively. These residues are unlikely to maintain the same For the 17 caspase-7 residues that mediate direct con- 
Protein Preparation
Assay for Caspase-7 Activity and Inhibition All constructs were generated using a standard PCR-based cloning Caspase-7 enzymatic assays were performed in a 20 l reaction strategy, and the identities of individual clones were verified through volume of buffer A (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM double-stranded plasmid sequencing. Because the N-terminal 50 MgCl 2 , 1 mM EDTA, 1mM EGTA, 1 mM dithiothreitol) at 37ЊC. In residues are unimportant for caspase-7 activity and disordered in Figure 6C , various concentrations of pure GST-XIAP linker peptide a reported crystal structure, they are removed in the caspase-7 (124-157) were incubated with caspase-7 (1 nM) and 100 M fluoroconstruct (residues 51-303). Caspase-7 and -3 were overexpressed genic peptide substrate DEVD-AFC for 30 min. The release of AFC in Escherichia coli strain BL21(DE3) as C-terminally 6-Histidinefrom the substrate was monitored using a PerkinElmer Life Sciences tagged proteins using a pET-21b vector (Novagen). The soluble luminescence spectrometer. In Figure 7A , effects of Smac/DIABLO fraction of the recombinant protein in the E. coli lysate was purified on XIAP inhibition of caspase-7 activity were determined by incubatover a Ni-NTA (Qiagen) column, and further fractionated by anion ing caspase-7 (1 nM) with 10 nM GST-XIAP (residues 124-240) and exchange (Source-15Q, Pharmacia) and gel-filtration chromatogra-500 nM of pure recombinant Smac in the presence of 100 M fluorophy (Superdex-200, Pharmacia). Recombinant XIAP fragments were genic peptide substrate DEVD-AFC. At different time intervals the overexpressed as GST-fusion proteins using pGEX-2T (Pharmacia). release of AFC from the substrate was monitored using a PerkinThe soluble fraction of the GST-IAP fusion in the E. coli lysate was Elmer Life Sciences luminescence spectrometer. The results were purified over a glutathione sepharose column, and further purified expressed as relative fluorogenic units of DEVD cleavage and shown by anion-exchange chromatography (Source-15Q, Pharmacia). The as the average of three independent experiments. purified GST-XIAP protein was immobilized onto glutathione resin and the purified caspase-7 was allowed to flow through the resin. The binary complex was eluted by reduced glutathione, cleaved by Isothermal Microcalorimetry Titration thrombin, and further purified through a gel filtration column.
All proteins and peptides were prepared in 50 mM sodium phosphate buffer, pH 7.5. The Micro Calorimetry System (Microcal, AmCrystallization and Data Collection herst, MA) was used to perform the ITC measurements for the interCrystals were grown by the hanging-drop vapor-diffusion method action between the linker peptide or GST-linker peptide and by mixing the caspase-7/XIAP complex (5 mg/ml) with an equal caspase-7. The titration data, collected at 23ЊC, were analyzed using volume of reservoir solution containing 25 mM Tris, pH 8.0, 0. 
